Recently, the United States Food and Drug Administration granted approval for Tzield (teplizumab-mzwv) injection: a groundbreaking treatment intended to obstruct the progression of stage 2 type 1 diabetes into its more serious form in adults as well as pediatric patients who are 8 years or older. John Sharretts, M.D., director …
Read More »Glycemic Control Stagnant in U.S. From 1988 to 2020
Mexican American adults receiving insulin less likely than non-Hispanic Whites to achieve glycemic control
Read More »Clinical Report Addresses Screening, Management of Congenital Hypothyroidism
When clinical symptoms and signs of hypothyroidism are present, TSH, free thyroxine should be measured, regardless of screening results
Read More »Risk for T2DM Reduced With Higher Daily Step Count
Hazard of incident diabetes reduced by 44 percent in adjusted models comparing average daily step count of 10,700 to 6,000
Read More »FDA Tobacco Unit Overloaded and Lacking Direction, Panel Says
Experts recommend agency leaders set clear objectives and expectations to prevent more 'detrimental’ effects on the agency's work and staff morale
Read More »Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
Read More »Not All Pediatric Cases of Type 2 Diabetes Have Obesity
Prevalence of obesity with type 2 diabetes highest in White children and lowest in Asian children
Read More »Lifestyle May Counter Genetic Risk for Thyroid Cancer
Highest risk for thyroid cancer seen among participants with both high genetic risk and unfavorable lifestyle
Read More »CDC Extends BMI-for-Age Growth Charts to Monitor Severe Obesity in Children, Adolescents
Extended method uses additional data from 1999 to 2016 NHANES, rather than extrapolation; improves characterization of extremely high BMI in children
Read More »Intermittent Fasting Can Achieve Remission in Type 2 Diabetes
44.4 percent of adults with T2D randomly assigned to Chinese Medical Nutrition Therapy had sustained remission after 12 months
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.